Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

AGA more common in men, Koreans have lower rates and unique patterns.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Minoxidil helps hair growth and reduces shedding in women.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Finasteride 2.5 mg/day can effectively treat female hair loss.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Finasteride improves hair density and thickness in women with hair loss.

Hair loss requires customized treatments based on its various causes and types.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

FDG PET/CT scans can change cancer treatment plans for dogs.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.